Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.21
Delayed Data
As of May 26
 +0.06 / +1.45%
Today’s Change
3.15
Today|||52-Week Range
10.06
+1.94%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close4.15
Today’s open4.13
Day’s range4.13 - 4.32
Volume1,382,402
Average volume (3 months)1,374,163
Market cap$575.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-52.00%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-0.23-0.76%
FLXNFlexion Therapeutics...-0.46-2.45%
INOInovio Pharmaceutica...-0.11-1.38%
PRTKParatek Pharmaceutic...-0.65-3.13%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Principal Accounting Officer &
Executive VP
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts